1. Home
  2. XBIT vs ALIS Comparison

XBIT vs ALIS Comparison

Compare XBIT & ALIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.36

Market Cap

74.4M

Sector

Health Care

ML Signal

HOLD

ALIS

Calisa Acquisition Corp Ordinary shares

N/A

Current Price

$10.16

Market Cap

85.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
ALIS
Founded
2005
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.4M
85.5M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
XBIT
ALIS
Price
$2.36
$10.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
29.4K
31.6K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$9.87
52 Week High
$3.61
$10.25

Technical Indicators

Market Signals
Indicator
XBIT
ALIS
Relative Strength Index (RSI) 46.97 60.56
Support Level $2.26 $10.05
Resistance Level $2.49 $10.17
Average True Range (ATR) 0.05 0.03
MACD 0.01 0.00
Stochastic Oscillator 29.59 35.71

Price Performance

Historical Comparison
XBIT
ALIS

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About ALIS Calisa Acquisition Corp Ordinary shares

Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.

Share on Social Networks: